Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Johnson & Johnson (NY: JNJ )

154.37 +0.02 (+0.01%)
Official Closing Price Updated: 7:00 PM EDT, May 30, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 5,593,082
Open 153.97
Bid (Size) 154.40 (1)
Ask (Size) 154.56 (1)
Prev. Close 154.35
Today's Range 153.32 - 155.38
52wk Range 150.11 - 183.35
Shares Outstanding 2,628,679,824
Dividend Yield 2.62%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Johnson & Johnson Unusual Options Activity
 
Via Benzinga
Nvidia Becomes Ninth Company To Hit $1 Trillion Market Cap — Who Could Be Next To Join Elusive Club?
A surge in price for shares of Nvidia Corporation (NASDAQ: NVDA) after the company’s quarterly earnings results and guidance has put the semiconductor company in the elusive $1 trillion market... 
Via Benzinga

Performance

YTD
-13.37%
-13.37%
1 Month
-5.64%
-5.64%
3 Month
+0.72%
+0.72%
6 Month
-12.33%
-12.33%
1 Year
-14.01%
-14.01%

More News

Read More
Kenvue's Growth Forecast: Exploring The Future Of Johnson & Johnson's Carve-Out
Via Benzinga
Expert Ratings for Johnson & Johnson
Via Benzinga
7 Undervalued Blue-Chip Stocks to Buy for June 2023
Via InvestorPlace
Check Out What Whales Are Doing With JNJ
Via Benzinga
Better Buy: Medtronic vs. Johnson & Johnson
Via The Motley Fool
Buy the Dip On These Warren Buffett Stocks
Via The Motley Fool
3 Dow Stocks Poised for a Roaring Relief Rally
Via InvestorPlace
Smokeless Tobacco Treatment Market to See Booming Growth : Novartis, Pfizer, Johnson & Johnson, Cambrex
Via SBWire
Exposures Climate
Want Passive Income Forever? Buy These 2 Magnificent Stocks Now
Via The Motley Fool
A Challenger to J&J's Top Blockbuster Is on the Way. Here's What You Need to Know.
Via The Motley Fool
Value Stocks Hit 15-Month Low Against Growth As AI Fuels Tech's Vengeance Over 2022's Rate-Hike-Induced Market Fall
Via Benzinga
Wall Street's Most Accurate Analysts Say Buy These 3 Health Care Stocks With Over 3% Dividend Yields
Via Benzinga
New Data Out Of Cleveland Clinic Shows BioSig PURE EP May Be Used For More Precise Approach For $6 Billion Annual Atrial Fibrillation Market
Via Benzinga
Ranked: Who Made The Most U.S. Unicorn Acquisitions Since 1997?
Via Talk Markets
7 Safe-Haven Stocks to Buy for Protection From a U.S. Debt Default Disaster
Via InvestorPlace
Buying These 2 Stocks Is a Good Way to Hedge Against a Market Crash
Via The Motley Fool
Will Dividends Take Center Stage In The Second Half Of 2023?
Via MarketBeat
Topics Artificial Intelligence
Exposures Artificial Intelligence
Rain Oncology Shares Plummet: Company Discloses Disappointing Cancer Study Data After Delaying Readout
Via Benzinga
Immix Biopharma's Subsidiary Says Investigational CAR T Therapy Shows 100% Response Rate In Amyloidosis
Via Benzinga
Got $1,000? 5 Buffett Stocks to Buy and Hold Forever
Via The Motley Fool
3 Relatively Safe Stocks to Buy if a Recession Is on the Way
Via The Motley Fool
WHO Recommends New COVID Booster Shots To Target XBB Variants, Despite Slower Uptake
Via Benzinga
FDA Approves First Oral Treatment For Crohn's Disease, Making Seventh Approval For AbbVie's Rinvoq
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.